Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1983-10-8
|
pubmed:abstractText |
The in vivo antitumor activity of NCS-immune immunoglobulin G (IgG) [Neocarzinostatin (NCS) conjugated with rabbit IgG antibody against a human leukemia cell line (NALL-1)] was evaluated in immunosuppressed newborn Syrian hamsters into which a transplantable human leukemia cell line, BALL-1 was implanted. After intraperitoneal (i.p.) injection of the conjugate, hamsters preinoculated i.p. with BALL-1 cells survived longer than hamsters treated with control solutions (p less than 0.01). The control solutions were NCS, immune IgG, a mixture of NCS and immune IgG, NCS-normal IgG conjugate and physiological saline. There was no change in body weight in the NCS-immune IgG-treated hamsters. The growth of subcutaneously (s.c.) implanted BALL-1 tumors was also inhibited by i.p. administration of NCS-immune IgG; however, the degree of inhibition was not significantly different from that obtained by administration of NCS alone, a mixture of NCS and immune IgG or NCS-normal IgG conjugate. These results indicate that NCS-immune IgG was effective against i.p. BALL-1 tumors, but was less effective against s.c. implanted tumors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0368-2811
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
425-33
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6224954-Animals,
pubmed-meshheading:6224954-Antibiotics, Antineoplastic,
pubmed-meshheading:6224954-Antibodies, Neoplasm,
pubmed-meshheading:6224954-Cell Line,
pubmed-meshheading:6224954-Cricetinae,
pubmed-meshheading:6224954-Humans,
pubmed-meshheading:6224954-Immunoglobulin G,
pubmed-meshheading:6224954-Leukemia, Experimental,
pubmed-meshheading:6224954-Leukemia, Lymphoid,
pubmed-meshheading:6224954-Mesocricetus,
pubmed-meshheading:6224954-Neoplasm Transplantation,
pubmed-meshheading:6224954-Zinostatin
|
pubmed:year |
1983
|
pubmed:articleTitle |
In vivo antitumor activity of neocarzinostatin (NCS)-tumor antibody conjugate against a transplantable human leukemia cell line (BALL-1).
|
pubmed:publicationType |
Journal Article
|